rewirebio.iobenchmarks
Evidence claim

Relevance of CPPC prospective nomination of desired T-cell states to "Select therapeutic targets for validation"

Use case
Select therapeutic targets for validation
Assessed by
CPPC prospective nomination of desired T-cell states
Relevance
Proxy evidence
Endpoint
Prospective nomination campaign: count of named targets improving the defined T-cell state objective.

Desired T-cell state changes provide experimentally measured target nomination evidence, but target efficacy/selectivity/rescue remain outside the measured endpoint.

1 reviewed evaluation

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

30 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Citation locations
2 values
  • source id
    ucc-research-source-challenge-paper
    locator
    Abstract; Challenge 2; Figure 5; README
  • source id
    ucc-research-source-challenge-code
    locator
    Abstract; Challenge 2; Figure 5; README
Context-only references
Cancer Immunotherapy Data Science Challenge official code

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371
Retrieved: 2026-09-30T21:26:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 4c4cdf5c4e13502f6caa73f38b2be191a7cd2b3d601aef72a81a6d1223681f66

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Citation locations
2 values
  • source id
    ucc-research-source-challenge-paper
    locator
    Abstract; Challenge 2; Figure 5; README
  • source id
    ucc-research-source-challenge-code
    locator
    Abstract; Challenge 2; Figure 5; README
Context-only references
Cancer Immunotherapy Data Science Challenge

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.64898/2026.05.21.726863v1; 2026 preprint
Retrieved: 2026-09-30T21:23:33Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 6c98a7d0f0ab7abff1c76a7f184382a10ca82c39b34879b83d205a994412aa22

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
2 values
  • Pooled nominations; not individual-method scores.
  • Mouse B16-OVA melanoma OT1 CD8 T-cell context.
Context-only references
Cancer Immunotherapy Data Science Challenge official code

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371
Retrieved: 2026-09-30T21:26:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 4c4cdf5c4e13502f6caa73f38b2be191a7cd2b3d601aef72a81a6d1223681f66

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
2 values
  • Pooled nominations; not individual-method scores.
  • Mouse B16-OVA melanoma OT1 CD8 T-cell context.
Context-only references
Cancer Immunotherapy Data Science Challenge

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.64898/2026.05.21.726863v1; 2026 preprint
Retrieved: 2026-09-30T21:23:33Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 6c98a7d0f0ab7abff1c76a7f184382a10ca82c39b34879b83d205a994412aa22

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
Prospective nomination campaign: count of named targets improving the defined T-cell state objective.
Context-only references
Cancer Immunotherapy Data Science Challenge official code

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371
Retrieved: 2026-09-30T21:26:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 4c4cdf5c4e13502f6caa73f38b2be191a7cd2b3d601aef72a81a6d1223681f66

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
Prospective nomination campaign: count of named targets improving the defined T-cell state objective.
Context-only references
Cancer Immunotherapy Data Science Challenge

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.64898/2026.05.21.726863v1; 2026 preprint
Retrieved: 2026-09-30T21:23:33Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 6c98a7d0f0ab7abff1c76a7f184382a10ca82c39b34879b83d205a994412aa22

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Claimed field
links:assessed_by:ucc-research-protocol-cppc-prospective-selection
Context-only references
Cancer Immunotherapy Data Science Challenge official code

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371
Retrieved: 2026-09-30T21:26:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: 4c4cdf5c4e13502f6caa73f38b2be191a7cd2b3d601aef72a81a6d1223681f66

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Claimed field
links:assessed_by:ucc-research-protocol-cppc-prospective-selection
Context-only references
Cancer Immunotherapy Data Science Challenge

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.64898/2026.05.21.726863v1; 2026 preprint
Retrieved: 2026-09-30T21:23:33Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: 6c98a7d0f0ab7abff1c76a7f184382a10ca82c39b34879b83d205a994412aa22

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Limitations
4 values
  • No matched-budget conventional/random prospective comparison; no antitumor efficacy, rescue or selectivity result in this endpoint.
  • 61 nominations / Results 57 selected targets / README 59 targets / 50 post-QC perturbations need reconciliation; no success fraction calculated.
  • Preprint v1; original and reimplemented ranking scores kept separate. Screen2 ranking population is enriched by original nomination methods.
  • Automated source review only; independent human scientific review remains outstanding.
Context-only references
Cancer Immunotherapy Data Science Challenge official code

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 283328a9b8afc6e882eeb503ac4710bbe9f37371
Retrieved: 2026-09-30T21:26:16Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.limitations

Source artifact SHA-256: 4c4cdf5c4e13502f6caa73f38b2be191a7cd2b3d601aef72a81a6d1223681f66

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Limitations
4 values
  • No matched-budget conventional/random prospective comparison; no antitumor efficacy, rescue or selectivity result in this endpoint.
  • 61 nominations / Results 57 selected targets / README 59 targets / 50 post-QC perturbations need reconciliation; no success fraction calculated.
  • Preprint v1; original and reimplemented ranking scores kept separate. Screen2 ranking population is enriched by original nomination methods.
  • Automated source review only; independent human scientific review remains outstanding.
Context-only references
Cancer Immunotherapy Data Science Challenge

Original source ↗

ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.64898/2026.05.21.726863v1; 2026 preprint
Retrieved: 2026-09-30T21:23:33Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.limitations

Source artifact SHA-256: 6c98a7d0f0ab7abff1c76a7f184382a10ca82c39b34879b83d205a994412aa22

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-20260930-346-910458dfd409

field
links:assessed_by:ucc-research-protocol-cppc-prospective-selection
value
ucc-research-protocol-cppc-prospective-selection
relevance
proxy
endpoint
Prospective nomination campaign: count of named targets improving the defined T-cell state objective.
rationale
Desired T-cell state changes provide experimentally measured target nomination evidence, but target efficacy/selectivity/rescue remain outside the measured endpoint.
constraints
Pooled nominations; not individual-method scores.; Mouse B16-OVA melanoma OT1 CD8 T-cell context.
limitations
No matched-budget conventional/random prospective comparison; no antitumor efficacy, rescue or selectivity result in this endpoint.; 61 nominations / Results 57 selected targets / README 59 targets / 50 post-QC perturbations need reconciliation; no success fraction calculated.; Preprint v1; original and reimplemented ranking scores kept separate. Screen2 ranking population is enriched by original nomination methods.; Automated source review only; independent human scientific review remains outstanding.
revision
1
reason
Add independently checked primary-source protocol evidence from the 17-use-case coverage audit; retain narrower endpoint and transfer limitations.
citation locators
source id: ucc-research-source-challenge-paper; locator: Abstract; Challenge 2; Figure 5; README; source id: ucc-research-source-challenge-code; locator: Abstract; Challenge 2; Figure 5; README
source locator
ucc-research-source-challenge-paper: Abstract; Challenge 2; Figure 5; README; ucc-research-source-challenge-code: Abstract; Challenge 2; Figure 5; README
review
method: automated-source-review; reviewer: codex; reviewer note: Codex source curation, independent worker cross-review and root integration review; reviewed at: 2026-09-30T21:54:30.217Z; note: Source-backed literature curation with independent automated transcription and scope checks. No new model execution, independent experimental replication, qualified human scientific review or clinical validation.
reviewed evaluations
ucc-research-eval-cppc-nominated-target-outcome
pins
record id: ucc-research-eval-cppc-nominated-target-outcome; fields: status; links; attributes.origin; attributes.comparison; sha256: 684176c1e8fe05a81b47abb7f69f8f1c6045fb264f9e165ba129f79adbfa61e9; record id: ucc-research-protocol-cppc-prospective-selection; fields: status; name; description; facets; source_ids; links; attributes; sha256: 39c63e680c2e163f90d984848f1ba4a9f1632834dda4eae29186ba63cad2254b; record id: ucc-research-result-cppc-nominated-target-outcome-named-desired-state-hits; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d743d517cdbace4d38c744688bbe023861c5f3a591ad92f5cb53369a820c0973; record id: ucc-research-source-challenge-code; fields: status; attributes.artifact_sha256; sha256: 8563974ad6eb67f251eccd6b608191b264bf7d35bf5024ed962982a8a3436f42; record id: ucc-research-source-challenge-paper; fields: status; attributes.artifact_sha256; sha256: 1b8bf53318d9c0b8488693b53f1981298c71d41c1dcf3667798bf75ffba54b29; record id: use-case-therapeutic-target-validation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 3b7601f2decfe5a3304ea2c8ccaa89929148f2d443b05bd6c9e92f1844c0a578
Related records

Suggest a correction